Xenetic Biosciences, Inc. today announced it has engaged Scott N. Cullison to serve as an executive consultant for business development and to support the advancement of the Company’s DNase-based oncology platform.
Xenetic Biosciences, Inc. today announced it has engaged Scott N. Cullison to serve as an executive consultant for business development and to support the advancement of the Company’s DNase-based oncology platform.